BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
197.50
-3.50 (-1.74%)
At close: May 23, 2025
Arcadium Lithium Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of 32.29 billion as of August 11, 2025. Its market cap has increased by 14.99% in one year.
Market Cap
32.29B
Enterprise Value
42.19B
Revenue
10.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
$197.50
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 69.93M to 32.29B, an increase of 46,078.48%. That is a compound annual growth rate of 21.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 32.29B | -0.51% |
Dec 31, 2024 | 32.46B | 56.49% |
Dec 29, 2023 | 20.74B | -50.32% |
Dec 30, 2022 | 41.75B | -18.29% |
Dec 31, 2021 | 51.09B | 95.19% |
Dec 31, 2020 | 26.17B | 161.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Wal-Mart de México | 975.39B |
Grupo Financiero Banorte | 469.39B |
Arca Continental | 334.30B |
Industrias Peñoles | 231.69B |
GMéxico Transportes | 142.42B |
FIBRA Prologis | 114.29B |
Fibra UNO | 99.85B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 99.11B |